Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Oct 1;73(4):471-477.
doi: 10.1097/MPG.0000000000003199.

Secondary Hepatic Injury in Pediatric Intensive Care: Risk Factors and Prognostic Impact

Affiliations
Observational Study

Secondary Hepatic Injury in Pediatric Intensive Care: Risk Factors and Prognostic Impact

Joana Direito et al. J Pediatr Gastroenterol Nutr. .

Abstract

Objectives: The aim of this study was to assess the profile of secondary hepatic injury (SHI), to determine risk factors and to evaluate its impact on prognosis of pediatric intensive care patients.

Methods: An exploratory observational and retrospective study was conducted in a Pediatric Intensive Care Unit. Two groups were defined: with SHI [alanine aminotransferase (ALT) ≥100 IU/L or gamma glutamyl transpeptidase (GGT)≥100 IU/L or direct bilirubin ≥30 μmol/L] and without. SHI was divided into 3 patterns: cytolysis, cholestasis, and mixed.

Results: SHI occurred in 16.5%, cytolysis in 5%, cholestasis in 4%, and mixed pattern in 7%. Independent risk factors for SHI were: organ dysfunction score PELOD-2 in D1 in cytolysis (n = 28); total parenteral nutrition and Pediatric Index of Mortality 3 (PIM3) in cholestasis (n = 23); sepsis, oncologic comorbidities, PIM3, and respiratory dysfunction in mixed pattern (n = 37). The ALT was an independent risk factor and a good predictor of mortality (AUC = 0.865) with a cut-off of 137 IU/L.

Conclusions: SHI was associated with worst prognostic. ALT may be useful for detecting patients at increased risk of death, probably being a surrogate marker of the illness severity, reflecting a secondary injury.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Comment in

References

    1. Yao Y, Wang D, Yin Y. Advances in sepsis-associated liver dysfunction. Burns Trauma 2014; 2:97–105.
    1. Mateos AGL, Montes JAR. Hepatotoxicidad en el paciente crítico. El hígado bajo agresión aguda grave. Nutr Hosp 2008; 23:19–24.
    1. Israelite JC. Pediatric parenteral nutrition-associated liver disease. J Infus Nurs 2017; 40:51–54.
    1. Horvatits T, Trauner M, Fuhrmann V. Hypoxic liver injury and cholestasis in critically ill patients. Curr Opin Crit Care 2013; 19:128–132.
    1. Tapper EB, Sengupta N, Bonder A. The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis. Am J Med 2015; 128:1314–1321.

Publication types

Substances